BCL2-Associated Athanogene 5 (BAG5) (N-Term) Peptide
Quick Overview for BCL2-Associated Athanogene 5 (BAG5) (N-Term) Peptide (ABIN8095465)
Target
Origin
Source
Application
-
-
Protein Region
- N-Term
-
Purpose
- BAG5 Peptide - N-terminal region
-
Sequence
- LSDDKNYKKL ERILTKQLFE IDSVDTEGKG DIQQARKRAA QETERLLKEL
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-BAG5 Antibody (ARP61997_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- BAG5 (BCL2-Associated Athanogene 5 (BAG5))
-
Background
-
Background Information: The protein encoded by this gene is a member of the BAG1-related protein family. BAG1 is an anti-apoptotic protein that functions through interactions with a variety of cell apoptosis and growth related proteins including BCL-2, Raf-protein kinase, steroid hormone receptors, growth factor receptors and members of the heat shock protein 70 kDa family. This protein contains a BAG domain near the C-terminus, which could bind and inhibit the chaperone activity of Hsc70/Hsp70. Three transcript variants encoding two different isoforms have been found for this gene.
Alternative Symbols: BAG-5
-
Molecular Weight
- 56kDa
-
Gene ID
- 9529
-
NCBI Accession
- NP_001015049
-
UniProt
- Q9UL15
Target
-